Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ergotamine induced ischemia].

A Remme1, A G Semb

  • 1Medisinsk avdeling, Moss sykehus.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|August 10, 1990
PubMed
Summary
This summary is machine-generated.

Ergotamine drugs for migraine can cause peripheral ischemia, a condition known as ergotism. Factors like fever, liver disease, and certain medications increase this risk, necessitating careful treatment strategies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.

Scandinavian journal of rheumatology·2022
Same author

Degree of arterial stiffness is comparable across inflammatory joint disease entities.

Scandinavian journal of rheumatology·2021
Same author

Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro <i>et al</i>.

Annals of the rheumatic diseases·2019
Same author

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.

BMC rheumatology·2019
Same author

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Annals of the rheumatic diseases·2016
Same author

Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.

International journal of cardiology·2016
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Area of Science:

  • Pharmacology
  • Toxicology
  • Neurology

Background:

  • Ergotamine-containing medications are standard migraine treatments.
  • Patient hypersensitivity can lead to adverse effects even at therapeutic doses.

Observation:

  • Hypersensitivity to ergotamine can induce peripheral ischemia.
  • Concurrent conditions (fever, liver disease) and drug interactions (erythromycin, propranolol) are risk factors for ergotism.

Findings:

  • This report details a case of ergotamine-induced peripheral ischemia.
  • Various treatment modalities for ergotism were explored.

Implications:

  • Highlights the importance of recognizing ergotamine hypersensitivity.
  • Informs clinical management of ergotism and associated risk factors.